Long-Acting Lenacapavir and Cabotegravir and Viral Suppression Among People With HIV
This case series examines viral suppression outcomes among patients with HIV with prior adherence challenges, treatment experience, and resistance initiating lenacapavir and cabotegravir.
Authors
- Francis Mayorga‐Munoz
- Chesa Cox (ORCID: https://orcid.org/0000-0002-5918-2668)
- Matthew A. Spinelli (ORCID: https://orcid.org/0000-0001-6368-8664)
- Monica Gandhi (ORCID: https://orcid.org/0000-0002-7025-1994)
- Mary Shiels
- Megan J. Heise (ORCID: https://orcid.org/0000-0001-6651-2381)
- Janet R. Grochowski (ORCID: https://orcid.org/0000-0002-9816-7073)
- Jon Oskarsson
- Nathanael L. Gistand
- Ishaan C. Mishra
- Kyle Hunter
Institutions
- University of California, San Francisco (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-10-08
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.38182
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00